Results 191 to 200 of about 75,915 (258)

Inhibition of acalabrutinib metabolism by finerenone and its molecular docking studies. [PDF]

Cell Biol Toxicol
Wang P, Fu H, Wu J, Li R, Cao L, Xu RA, Lin W.   +6 more
europepmc   +1 more source

New Insights into Prostate Cancer Susceptibility in European Caucasians: A Systematic Review and Meta-Analysis of CYP3A4 Pharmacogene. [PDF]

Cancers (Basel)
Pagoni M, Cava C, Tsangaris GT, Siannis F, Drakoulis N.   +4 more
europepmc   +1 more source

The Effect of Ecopipam on the Pharmacokinetics of Concomitant Medications. [PDF]

Clin Transl Sci
Schmith VD, Graden D, Lohmer LLR, Schleyer J, Wanaski SP.   +4 more
europepmc   +1 more source

Molecular dynamics simulations elucidate the role of the F-F' loop in substrate entry into CYP3A4. [PDF]

Commun Chem
Yan J, Hirao H.
europepmc   +1 more source

A new metabolic path in type 3 rickets. [PDF]

FEBS J
Senda T, Hirota Y.
europepmc   +1 more source

Allelic variation in CYP3A4 and PLB1 drives feed efficiency and immunometabolic resilience in beef cattle. [PDF]

BMC Genomics
Morenikeji OB, Idowu M, Taiwo G, Gratz LM, Olabosoye B, King RE, Andrews ND, Saccoh F, Grytsay A, Marshall MC, Ogunade IM.   +10 more
europepmc   +1 more source

Potential Drug Interactions in Psychiatric Patients Undergoing Pangenotypic Therapy for Hepatitis C Virus Infection. [PDF]

Pharmaceuticals (Basel)
Dybowska D, Pawłowska M, Kozielewicz D.
europepmc   +1 more source

Etoposide dosing challenges in a testicular cancer patient with hepatic impairment and drug-drug interactions-a case report. [PDF]

Cancer Chemother Pharmacol
Op 't Hoog CJP, de Jong LAW, Sijm J, Smits M, Mulder SF, Boerrigter E.   +5 more
europepmc   +1 more source

Drug-drug interactions in targeted cancer therapies: a focus on tyrosine kinase inhibitors. [PDF]

Expert Rev Clin Pharmacol
Stromatt JC, Chowdhury AT, Huang KM, Hu S, Sparreboom A, Baker SD, Eisenmann ED.   +6 more
europepmc   +1 more source

Unexpected Clinical Drug-Drug Interaction of Fexinidazole on Midazolam Pharmacokinetics: Insights into Underlying Mechanisms from Clinical Phase I Study Results and Supporting In Vivo/Vitro Evidence. [PDF]

Clin Drug Investig
Gassiot M, Brun P, Wauthier V, Da Silva F, Nicolas O, Hays S, Sultan E.   +6 more
europepmc   +1 more source